Fibrinogen-albumin ratio predicting major adverse cardiovascular outcomes post-percutaneous coronary intervention: A systematic review and exploratory meta-analysis

Clin Cardiol. 2023 Apr;46(4):455-458. doi: 10.1002/clc.23981. Epub 2023 Feb 1.

Authors

Rupak Desai¹, Kahtan Fadah², Sashwath Srikanth³, N F N Neha⁴, Akhil Jain⁵

Affiliations

¹ Independent Outcomes Researcher, Atlanta, Georgia, USA.
² Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA.
³ Department of Internal Medicine, East Carolina University - Vidant Medical Center, Greenville, North Carolina, USA.
⁴ Department of Medicine, Uzhhorod National University, Uzhhorod, Ukraine.
⁵ Department of Internal Medicine, Mercy Catholic Medical Center, Darby, Pennsylvania, USA.

No abstract available

Publication types

Systematic Review
Meta-Analysis
Letter

MeSH terms

Albumins
Cardiovascular System*
Coronary Artery Disease* / etiology
Coronary Artery Disease* / therapy
Fibrinogen
Humans
Percutaneous Coronary Intervention* / adverse effects
Treatment Outcome

Substances

Albumins
Fibrinogen